44 results on '"Bi, Yanghui"'
Search Results
2. Tumor-derived extracellular vesicle drug delivery system for chemo-photothermal-immune combination cancer treatment
3. Characterization of somatic structural variations in 528 Chinese individuals with Esophageal squamous cell carcinoma
4. The Chemo-Immunotherapeutic Roles of Tumor-Derived Extracellular Vesicle-Based Paclitaxel Delivery System in Hepatocarcinoma.
5. Expression and purification of asprosin in Pichia pastoris and investigation of its increase glucose uptake activity in skeletal muscle through activation of AMPK
6. Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing
7. FBXW7 inhibits the progression of ESCC by directly inhibiting the stemness of tumor cells
8. FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer
9. Decreased ZNF750 promotes angiogenesis in a paracrine manner via activating DANCR/miR-4707-3p/FOXC2 axis in esophageal squamous cell carcinoma
10. Hepatic G Protein-Coupled Receptor 180 Deficiency Ameliorates High Fat Diet-Induced Lipid Accumulation via the Gi-PKA-SREBP Pathway
11. FBXW7 inhibits the Progression of ESCC by directly inhibiting the Stemness of Tumor Cells
12. FBXW7 as a potential prognostic biomarker for ESCC inhibits the progression of ESCC by directly inhibiting the stemness of tumor cells
13. Oncogenic B-RafV600E abrogates the AKT/B-Raf/Mps1 interaction in melanoma cells
14. Tag SNPs of CFI contributed to the susceptibility for non-small cell lung cancer in Chinese population
15. The Role of DBR1 as a Candidate Prognosis Biomarker in Esophageal Squamous Cell Carcinoma
16. CDCA7 Facilitates Tumor Progression by Directly Regulating CCNA2 Expression in Esophageal Squamous Cell Carcinoma
17. Artesunate alleviates hepatic fibrosis induced by multiple pathogenic factors and inflammation through the inhibition of LPS/TLR4/NF-κB signaling pathway in rats
18. Corrigendum to “FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer” [Canc. Lett. 397 (2017) 83–93]
19. Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma
20. TSTA3 facilitates esophageal squamous cell carcinoma progression through regulating fucosylation of LAMP2 and ERBB2
21. MYH9 promotes cell metastasis via inducing Angiogenesis and Epithelial Mesenchymal Transition in Esophageal Squamous Cell Carcinoma
22. Novel ESCC-related gene ZNF750 as potential Prognostic biomarker and inhibits Epithelial-Mesenchymal Transition through directly depressing SNAI1 promoter in ESCC
23. Potential Role of Targeting KDR and Proteasome Inhibitors in the Therapy of Esophageal Squamous Cell Carcinoma
24. Mps1 is associated with the BRAFV600E mutation and predicts poor outcome in patients with colorectal cancer
25. EP300 as an oncogene correlates with poor prognosis in esophageal squamous carcinoma
26. Recent advances in research on aspartate β-hydroxylase (ASPH) in pancreatic cancer: A brief update
27. FAT1 inhibits cell migration and invasion by affecting cellular mechanical properties in esophageal squamous cell carcinoma
28. WITHDRAWN: Potential therapeutic targets screening for esophageal squamous cell carcinoma via combined analysis of genomic sequencing data and target pharmacophore database
29. High TSTA3 Expression as a Candidate Biomarker for Poor Prognosis of Patients With ESCC
30. WITHDRAWN: EP300 promotes tumor development and correlates with poor prognosis in esophageal squamous carcinoma
31. The macro-evolutionary events in esophageal squamous cell carcinoma
32. Mps1 is associated with the BRAFV600E mutation and predicts poor outcome in patients with colorectal cancer.
33. Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma
34. Genomic analyses reveal FAM84B and the NOTCH pathway are associated with the progression of esophageal squamous cell carcinoma
35. Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma
36. Mutually exclusive mutations inNOTCH1andPIK3CAassociated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China
37. Artesunate altered cellular mechanical properties leading to deregulation of cell proliferation and migration in esophageal squamous cell carcinoma
38. Tag SNPs of CFI contributed to the susceptibility for non-small cell lung cancer in Chinese population
39. Rspo2-LGR4 exacerbates hepatocellular carcinoma progression via activation of Wnt/β-catenin signaling pathway
40. The Role of DBR1as a Candidate Prognosis Biomarker in Esophageal Squamous Cell Carcinoma
41. Oncogenic B-RafV600E abrogates the AKT/B-Raf/Mps1 interaction in melanoma cells.
42. Mps1 is associated with the BRAF V600E mutation and predicts poor outcome in patients with colorectal cancer.
43. Mutually exclusive mutations in NOTCH1 and PIK3CA associated with clinical prognosis and chemotherapy responses of esophageal squamous cell carcinoma in China.
44. [Study of negative feedback between wild-type BRAF or RAFV600E and Mps1 in melanoma].
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.